Close Menu
Himanshu Agarwal, MD

Assistant Professor


School of Medicine
Department of Medicine
Cardiology Division
Interventional Cardiology Fellowship

Himanshu Agarwal, MD

Assistant Professor




Assistant Professor


  • J American College of Cardiology Cardiovascular Interv
    Aggarwal, G, Delcore, M; Agarwal, H. Transcatheter Aortic Valve Replacement With Self-Expanding Acurate Neo2 Valve Versus Acurate Neo Valve: A Meta-Analysis. . G Aggarwal, M Delcore, H Agarwal et al J Am Coll Cardiol Intv 2023 Feb, 16 (4_Supplement) S88-89, p. S88-89 2023
  • J American College of Cardiology Cardiovascular Interv
    Aggarwal, G, M Delcore, H Agarwal Left Atrial Appendage Occlusion With Watchman® Device in Patients With Non-Valvular Atrial Fibrillation and End-Stage Chronic Kidney Disease on Hemodialysis J Am Coll Cardiol Intv 2023 Feb, 16 (4_Supplement) S88-89 J Am Coll Cardiol Intv 2023 Feb, 16 (4_Supplement) S102plement) S102 2023
  • J American College of Cardiology Cardiovascular Interv
    Aggarwal, G, DelCore, M; Agarwal, H Orbital Atherectomy During Percutaneous Coronary Intervention for Severely Calcified Coronary Lesions in Patients With and Without Diabetes Mellitus: A Meta-Ananlysis. G Aggarwal, M Delcore, H Agarwal et al J Am Coll Cardiol Intv 2023 Feb, 16 (4_Supplement) S96–S97 2023
  • Catheter Cardiovasc Interv
    Ismayl, M, M Balakrishna, A; M Fahmy, M; Thandra, A; Gill, G; Hiu, F; Agarwal, H Impact of sex on in hospital mortality and 90-day readmissions in patients undergoing transcatheter mitral valve replacement (TMVR): Analysis from nationwide readmission database. Mahmoud Ismayl MD, Akshay Machanahalli Balakrishna MD, Mostafa Mahmoud Fahmy MD, Abhishek Thandra MD, Gauravpal S. Gill MD, Fang Niu PhD, Himanshu Agarwal MD et al. Catheter Cardiovasc Interv. 2023 Jan 8. doi: 10.1002/ccd.30549. Online ahead of print.PMID: 36617383 2023
  • Coronary Artery Diesease
    Thandra, A, Agarwal, H Sex difference in clinical and procedural outcomes in patients undergoing coronary atherectomy; a systematic review and metanalysis. Thandra A, Agarwal H et. Al Coron Artery Dis. 2022 Dec 1;33(8):634-642. doi10.1097/MCA.0000000000001187. Epub 2022 Oct 17.PMID: 36238981
    33, p. 634-642 2022
  • New England Journal of Medicine
    Kapadia, SR, Makkar, R; Leon, M; Agarwal, H Cerebral Embolic Protection during Transcatheter Aortic-Valve replacement. Kapadia SR, Makkar R, Leon M, Agarwal H et al. PROTECTED TAVR investigators N Engl J Med. 2022 Oct 6 ; 387 (14) :1253-1263
    387, p. 1253-1263 2022
  • Circulation
    Hagstrom, E, Steg, PG, Szarek, M; Bhatt, DL, Bittner, VA; Danchin, N; Agarwal, H Apolipoprotien B, Residual Cardiovascular Risk after Acute Coronary Syndrome, and effects of Alirocumab Hagström E, Steg PG, Szarek M, Bhatt DL, Bittner VA, Danchin N, Agarwal H et. al ; ODYSSEY OUTCOMES Investigators. Circulation. 2022 Aug 30;146(9):657-672. doi: 10.1161
    146, p. 657-672 2022
  • N Engl J Med
    Schwartz GG, Steg PG, , Zeiher AM. Agarwal H , et al. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018 Nov 29;379(22):2097-2107 2021
  • Lancet Diabetes Endocrinol
    Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol J Am Coll Cardiol 2021 Aug 3;78(5):421-433. Gregory G Schwartz 1 , Michael Szarek 2 , Vera A Bittner, H. Agarwal et al. ODYSSEY Outcomes Committees and Investigators. 2021
  • Journal of American College of Cardiology
    Predictors of Device-Related Thrombus Following Percutaneous Left Atrial Appendage Occlusion: Simard T, Jung , Alkhouli M, Agarwal H Journal of American College of Cardiology ; Volume 78, Issue 4Pages A1-A36, e19-e24, 297-420, (27 July 2021 2021
  • Diabetes Care
    Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment. Schwartz GG, Szarek M, Bittner VA, Bhatt DL, Diaz R, Goodman SG, Jukema JW, Loy M, Manvelian G, Pordy R, White HD, Steg PG; ODYSSEY OUTCOMES Committees and Investigators. Diabetes Care. 2021 May;44(5):1219-1227. 10.2337/dc20-2842 2021
  • JACC Case Report
    Left Atrial Appendage Closure in a Patient With a Patent Foramen Ovale Septal Occluder Device Omar Kousa 1 , Toufik Mahfood-Haddad 1 , Shantanu M Patil 1 , Himanshu Agarwal 1 , Hussam Abuissa ACC Case Rep 2021 Mar 17;3(3):508-511 2021
  • Heart Rhythm Case Reports
    Left atrial appendage closure in a patient with situs inversus totalis and interrupted inferior vena cava - A transhepatic approach.Tandon TS, Agarwal H, Alla VM, Abuissa HS. HeartRhythm Case Rep. 2020 Sep 15;6(11):871-874. 2020
  • J American College of Cardiology Cardiovascular Interv
    Van Mieghem NM, Popma JJ, Reardon M, Agarwal, H et al . Complete 2-Year Results Confirm Bayesian Analysis of the SURTAVI Trial. JACC Cardiovasc Interv2020 Feb 10;13(3):323-33 2020
  • Lancet Diabetes Endocrinol
    Ray KK, Colhoun HM, Szarek M, Steg PG, Agarwal H et al. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial. Lancet Diabetes Endocrinol. 2019 Aug;7(8):618-628 2019
  • J American College of Cardiology Cardiovascular Interv
    Massive Inferior Vena Cava Thrombosis Associated With Retroperitoneal Venolymphatic Malformation Raviteja R. Guddeti, Geetanjali Dang MD, Abilash AkinapelliMD, Himanshu AgarwalMD and Joseph StavasMD J Am Coll Cardiol Cardiovasc Interv. 2018 Nov, 11 (22) e187–e188. 2018
  • J Am Coll Cardiol
    Outcomes of Drug-Eluting versus Bare-Metal Stents in Saphenous Vein Graft Lesions: A Meta-Analysis of Randomized Controlled Trials Toufik Mahfood Haddad, Aravdeep Jhand, Jai Parekh, Luay Sarsam, Abdul Saadi, Aiman Smer, Himanshu Agarwal, Michael Delcore and Venkata M. Alla. J Am Coll Cardiol. 2018 Sep, 72 (13_Supplement) B112 2018
  • N Engl J Med
    Reardon MJ, Van Mieghem NM, , Kappetein AP Agarwal H; Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. Second Generation Versus First Generation Transcatheter Aortic Valve Replacement: A Meta-analysis :N Engl J Med. 2017 Apr 6;376(14):1321-1331 2017
  • J Am Coll Cardiol
    Arun Kanmanthareddy, Dixitha Anugula, Sameer Gafoor, Rahul Sharma, Claire Hunter, Scott Lilly, Michael White, Michael Del Core, Himanshu Agarwal, Dennis Esterbrooks, Aryan Mooss and Venkata Alla. J Am Coll Cardiol Cardiovasc Interv. 2017 Feb, 10 (3_Supplement) S71 2017
  • J Am Coll Cardiol
    Van Mieghem, N, Deeb, G.M.; Sondergaard, L; Agarwal, H Self -expanding Transcatheter vs Surgical AVR in Intermediate risk patients:5 year outcomes of the SURTAVI Randomized Clinical trial Nicolas M. Van Mieghem, MD, ; G. Michael Deeb, MD, Lars Søndergaard, MD, PhD,Agarwal H; et al JAMA Cardiol. 2022;7(10):1000-1008. doi:10.1001/jamacardio.2022.2695
    7, p. 1000-1008 -0001


  • CHAMPION AF: Principal Investigator WATCHMAN FLX versus DOAC for Embolic Protection in the Management of Non-Valvular Atrial Fibrillation (NVAF) Patients

  • CATALYST AF : Principal investigator. Amplatzer Amulet vs NOAC for Stroke prevention in patients of Non Valvular Atrial Fibrillation

  • PROTECTED-TAVR: PrincipalInvestigator, Stroke PROTECTion with SEntinel During Transcatheter Aortic Valve Replacement

  • WATCH-TAVR: Principal Investigator WATCHMAN For Patients with Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement (TAVR)